HIV / AIDS
IAS 2011: Stakeholders Call for HIV Cure Research
- Details
- Category: Search for a Cure
- Published on Tuesday, 19 July 2011 00:00
Over the past few years a cure for HIV has again become a goal of HIV/AIDS research. The International AIDS Society is a leading proponent of greater investment in cure-related science. 
IAS 2011: HIV Treatment as Prevention: HPTN 052 Offers Proof [VIDEO]
- Details
- Category: Treatment as Prevention/Test & Treat
- Published on Tuesday, 19 July 2011 00:00
HPTN 052 lead investigator Myron Cohen talked to Paul Dalton from HIVandHepatitis.com about the study's findings and their significance. 
IAS 2011: Transplants Safe for HIV+ People but HCV Adds Risk
- Details
- Category: Liver & Kidney Disease
- Published on Monday, 18 July 2011 00:00
Kidney and Liver transplants can be safe and effective for people living with HIV. However hepatitis C virus (HCV) coinfection and several other factors may make such procedures more risky. 
IAS 2011: Changing Face of HIV Vaccine Research [VIDEO]
- Details
- Category: HIV Prevention
- Published on Monday, 18 July 2011 00:00
Gary Nabel, Director of the National Institutes of Health Vaccine Research Center, presented an overview of the promises and pitfalls of HIV vaccine research in a plenary talk and press conference at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) this week in Rome. 
IAS 2011: Studies Confirm PrEP, Early ART Prevent HIV Transmission [VIDEO]
- Details
- Category: HIV Prevention
- Published on Monday, 18 July 2011 00:00
Researchers at the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) taking place this week in Rome presented eagerly awaited data from 3 large trials showing that starting combination antiretroviral therapy (ART) early, and pre-exposure prophylaxis (PrEP) using tenofovir/emtricitabine, can dramatically cut the risk of HIV transmission.
Medicines Patent Pool Licenses First HIV and HBV Drugs
- Details
- Category: Drug Pricing & Patents
- Published on Monday, 18 July 2011 00:00
UNITAID and the Medicines Patent Pool -- an initiative to make drugs more widely available at reduced cost -- announced its first pharmaceutical company agreement. Gilead Sciences licensed 4 drugs, including the popular tenofovir for treatment of HIV and hepatitis B, as well as coformulation including Truvada and the experimental Quad pill.
IAS 2011: Universal Access to Science [VIDEO]
- Details
- Category: HIV Policy & Advocacy
- Published on Sunday, 17 July 2011 11:00
Michel Sidibé, Executive Director of UNAIDS, spoke Sunday, July 7, at the opening plenary and press conference of the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011).
Web Design and Development by